H101

AXP000003.1 · Oncolytic virus

Platform
adenovirus (Ad5, E1B-55kDa and partial E3 deleted)
Originator
Shanghai Sunway Biotech
Sponsor
Shanghai Sunway Biotech

Names

NameTypeSource
H101preferred name, codecurator, ncit
Oncorinebrandncit
Oncolytic Adenovirus H101synonympress
rAd5 H101synonymncit
Recombinant Human Adenovirus Type 5 H101synonymncit
Recombinant Human Adenovirus Type 5 Injection ambiguoussynonymctgov

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5 (H101)
Replication
conditionally replicating
Modifications
E1B-55kDa deleted; partial E3 deletion
Route
intratumoral, intra arterial, intraperitoneal
Source
evidence

Cross-references

NCI Thesaurus
C107504
FDA UNII
QH36X20ODG

Approvals

AgencyRegionDateStatusBrandIndicationSource
NMPACN2005-11approvedOncorineNasopharyngeal/head and neck squamous cell carcinoma, by intratumoral injection in combination with cisplatin-based chemotherapysource

Clinical trials (21)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT06196671Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic CancerNot yet recruitingPhase 22026-12-012028-01-0130Pancreatic Cancer
NCT07381309Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLMNot yet recruitingPhase 22026-06-012028-02-01114CRC; Liver Metastasis Colon Cancer
NCT07543848A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal CancerNot yet recruitingPhase 22026-05-012028-12-3120Rectal Adenocarcinoma; Rectal Neoplasms
NCT07398664H101 Plus TACE for r/m HNSCCRecruitingPhase 22026-03-022028-06-1520Head and Neck Squamous Cell Carcinoma; Oncolytic Virus; TACE
NCT06919848Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)Not yet recruitingPhase 22025-05-012027-05-0174Biliary Tract Cancer (BTC)
NCT06253598Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular CarcinomaNot yet recruitingPhase 22024-03-302025-12-3030Hepatocellular Carcinoma
NCT06031636Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural MesotheliomaUnknown2023-07-202026-07-3115Malignant Pleural Mesothelioma, Advanced
NCT05872841H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein ThrombosisUnknownPhase 22023-06-012024-12-3138Portal Vein Thrombosis; Primary Hepatocellular Carcinoma
NCT05823987Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05)UnknownPhase 22023-05-162025-12-3025Advanced Biliary Tract Cancer
NCT06136910Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung CancerUnknownPhase 1/22023-05-092024-05-0930Untreated Advanced Non-small Cell Lung Cancer
NCT05675462Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular CarcinomaUnknownPhase 12023-03-012025-12-3025Hepatocellular Carcinoma
NCT05664139Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant MelanomaUnknownPhase 22023-022024-1230Liver Metastases; Malignant Melanoma
NCT05124002Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic CholangiocarcinomaUnknownPhase 42022-08-012026-04-0166Cholangiocarcinoma, Intrahepatic
NCT05303844Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant AscitesUnknownPhase 12022-04-022025-03-2025Refractory Malignant Ascites
NCT05303090Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic CancerCompletedPhase 12022-03-312024-04-2356Pancreatic Ductal Adenocarcinoma
NCT05234905H101 Combined With Camrelizumab for Recurrent Cervical CancerUnknownPhase 22022-032023-0655Camrelizumab; Oncolytic Virotherapy; Uterine Cervical Neoplasms
NCT05051696Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological MalignanciesUnknownPhase 22021-09-262024-03-30120Genital Neoplasms, Female
NCT04771676Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant AscitesCompletedPhase 22021-03-052023-01-3125Refractory Malignant Ascites
NCT03780049HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-BUnknownPhase 32018-10-012023-10-01304Hepatocellular Carcinoma
NCT03790059Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.Unknown2016-102020-09160Hepatocellular Carcinoma
NCT02579564Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC PatientsUnknownPhase 32016-102018-06134Malignant Hydrothorax; Non Small Cell Lung Cancer
Unconfirmed matches (8)

Trials that mention one of the names in a weaker way (a code only in the title, a short or ambiguous name). Not counted above.

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditionsMatched by
NCT07850869A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With Immune Checkpoint Inhibitors for Advanced Metastatic Breast CancerRecruiting2026-09-092028-02-2915Breast Cancer (Locally Advanced or Metastatic)name in title: H101
NCT07356791Phase II Prospective Cohort Study of Intravesical Recombinant Human Type 5 Adenovirus Injection for Treatment of High-Risk Non-Muscle Invasive Bladder Cancer: Evaluating Efficacy and SafetyNot yet recruitingPhase 22026-02-012026-12-3118Bladder (Urothelial, Transitional Cell) Cancerintervention named: Recombinant Human Adenovirus Type 5 Injection
NCT06685354Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot StudyUnknownPhase 22024-112026-1011Hepatocellular Carcinoma (HCC)name in title: H101
NCT06455046Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical CancerUnknownPhase 22023-10-112025-10-1037Cervical Cancer Recurrentintervention named: Recombinant Human Adenovirus Type 5 Injection
NCT05928962An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant MelanomasUnknownPhase 12022-10-272023-08-0110Malignant Melanomasintervention named: Recombinant Human Adenovirus Type 5 Injection
NCT05564897Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder CancerUnknownPhase 22022-08-262024-09-3025Bladder Cancername in intervention: H101
NCT05113290Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib TreatmentUnknownPhase 42021-12-282023-12-0166Hepatocellular Carcinomaintervention named: Recombinant Human Adenovirus Type 5 Injection
NCT01869088TACE Plus Recombinant Human Adenovirus for Hepatocellular CarcinomaUnknownPhase 32013-012018-01266Hepatocellular Carcinomaintervention named: Recombinant Human Adenovirus Type 5 Injection

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 41859855The safety and efficacy of recombinant human adenovirus 5 injection (H101) intraperitoneal administration combined with tislelizumab and platinum, fluorouracil-based drugs in the treatment of gastric cancer with peritoneal metastasis: an open-label, single-arm, prospective clinical study protocol.Future oncology (London, England)2026name in title: H101
PMID 40667543Induction of abscopal effect combining H101 oncolytic virotherapy with tislelizumab in a patient with advanced hepatocellular carcinoma: a case report.American journal of cancer research2025name in title: H101
PMID 40812353Locoregional Treatment Options for Locally Advanced Intrahepatic Cholangiocarcinoma.Journal of the National Comprehensive Cancer Network : JNCCN2025cited by trial NCT05124002
PMID 41357181Case report: Local and systemic combination therapy: endoscopic injection of an oncolytic virus with PD-1 inhibitor for an elderly patient with advanced gastrointestinal cancer.Frontiers in immunology2025name in abstract: Oncolytic Adenovirus H101
PMID 38659226Oncolytic adenovirus in treating malignant ascites: A phase II trial and longitudinal single-cell study.Molecular therapy : the journal of the American Society of Gene Therapy2024cited by trial NCT04771676
PMID 38978969A Case Report of Pathologically Complete Response of a Huge Lymph Node Metastasis of Colorectal Cancer After Treatment with Intratumoral Oncolytic Virus H101 and Capecitabine.ImmunoTargets and therapy2024name in title: H101
PMID 39588306Reverse resistance to immune checkpoint inhibitor in a patient with recurrent cardia cancer by intratumoral injection of recombinant human adenovirus type 5: a case report and literature review.Frontiers in oncology2024name in abstract: Recombinant Human Adenovirus Type 5 H101
PMID 37675621Effectiveness and safety of human type 5 recombinant adenovirus (H101) in malignant tumor with malignant pleural effusion and ascites: A multicenter, observational, real-world study.Thoracic cancer2023name in title: H101
PMID 35399603Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response.Molecular therapy oncolytics2022cited by trial NCT06196671
PMID 33760389Recombinant human adenovirus type 5 (Oncorine) reverses resistance to immune checkpoint inhibitor in a patient with recurrent non-small cell lung cancer: A case report.Thoracic cancer2021name in title: Oncorine
PMID 35071441Successful treatment of a 19-year-old patient with locally advanced clear cell adenocarcinoma of the uterine cervix using recombinant human adenovirus type 5 (Oncorine) combined with chemoradiotherapy: a case report.Annals of translational medicine2021name in title: Oncorine
PMID 32067509Combination therapy with oncolytic viruses and immune checkpoint inhibitors.Expert opinion on biological therapy2020cited by trial NCT06196671
PMID 21633603Transarterial injection of H101 in combination with chemoembolization overcomes recurrent hepatocellular carcinoma.World journal of gastroenterology2011name in title: H101
PMID 15534920Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trial.World journal of gastroenterology2004name in title: H101
PMID 15601557[Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus].Ai zheng = Aizheng = Chinese journal of cancer2004name in title: H101
PMID 14693057[Phase II clinical study of intratumoral H101, an E1B deleted adenovirus, in combination with chemotherapy in patients with cancer].Ai zheng = Aizheng = Chinese journal of cancer2003name in title: H101
Unconfirmed matches (3)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 42022327Case Report: Integration of intratumoral oncolytic adenovirus with total neoadjuvant therapy in metachronous locally advanced rectal cancer.Frontiers in oncology2026name in abstract: H101
PMID 40661951Overcoming immune resistance in advanced esophageal squamous cell carcinoma with recombinant human adenovirus type 5 by impacting the immune microenvironment: a case report.Frontiers in immunology2025name in abstract: H101
PMID 8226457Changes in hormonal concentrations after different heavy-resistance exercise protocols in women.Journal of applied physiology (Bethesda, Md. : 1985)1993name in abstract: H101

Other papers

Preclinical studies, reviews and other papers that name it, newest 100 shown.

PubMedTitleJournalYearLinked by
PMID 40329730Talimogene Laherparepvec (T-VEC): Expanding Horizons in Oncolytic Viral Therapy Across Multiple Cancer Types.Anti-cancer agents in medicinal chemistry2026name in abstract: Oncorine
PMID 41675687Strategically engineering an oncolytic herpes simplex virus to improve systemic delivery.Molecular therapy. Oncology2026name in abstract: Oncorine
PMID 41953007Recombinant human adenovirus type 5 synergizes with anti-PD-L1 antibody to promote anti-hepatocellular carcinoma effects through multilevel remodeling of the immune microenvironment.Frontiers in immunology2026name in abstract: Recombinant Human Adenovirus Type 5 H101
PMID 42000628Oncolytic human adenovirus 5 (H101) modulates cell cycle progression in HPV16-positive tumors.Biochemical and biophysical research communications2026name in title: H101
PMID 42161529PRXL2B facilitates the progression of hepatocellular carcinoma and the therapeutic efficacy of oncolytic adenovirus H101 through the PI3K/AKT/PD-L1 axis.Bioscience trends2026name in title: Oncolytic Adenovirus H101
PMID 42216079Recent advances in oncolytic virotherapy: insights from clinical trials and combination treatment strategies.Virology journal2026name in abstract: Oncorine
PMID 42528584Short-term efficacy and safety of recombinant human adenovirus type 5 combined with PD-1 immune checkpoint inhibitors and SOX regimen in neoadjuvant therapy of locally advanced gastric cancer: a retrospective study.Frontiers in oncology2026name in abstract: Recombinant Human Adenovirus Type 5 H101
PMID 40170848Enhancing pancreatic cancer treatment: the role of H101 oncolytic virus in irreversible electroporation.Frontiers in immunology2025name in title: H101
PMID 40296909Oncolytic adenovirus H101 enhances the anti-tumor effects of PD-1 blockade via CD47 downregulation in tumor cells.Oncology research2025name in title: Oncolytic Adenovirus H101
PMID 40881284Oncolytic viruses in head and neck cancers: clinical applications and therapeutic potential.Frontiers in microbiology2025name in abstract: Oncorine
PMID 41049859The combination treatment of oncolytic adenovirus H101 with transcatheter arterial embolization sequential thermal ablation for hepatocellular carcinoma: a retrospective study.Frontiers in oncology2025name in title: Oncolytic Adenovirus H101
PMID 41403317Recombinant human type-5 adenovirus (H101) combined with radiofrequency ablation versus traditional radiofrequency ablation for hepatocellular carcinoma ≤ 3 cm: a phase III randomized controlled trial.International journal of surgery (London, England)2025name in title: H101
PMID 38325225The combination treatment of oncolytic adenovirus H101 with nivolumab for refractory advanced hepatocellular carcinoma: an open-label, single-arm, pilot study.ESMO open2024name in title: Oncolytic Adenovirus H101
PMID 38576614New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy.Frontiers in immunology2024name in abstract: Oncorine
PMID 38782895Induced dual-target rebalance simultaneously enhances efficient therapeutical efficacy in tumors.Cell death discovery2024name in abstract: Oncolytic Adenovirus H101
PMID 39238337Correction to "The Oncolytic Virus H101 Combined with Gnaq Sirna-Mediated Knockdown Reduces Uveal Melanoma Cell Viability".Journal of cellular biochemistry2024name in title: H101
PMID 36299168Oncolytic virus preclinical toxicology studies.Journal of applied toxicology : JAT2023name in abstract: Oncorine
PMID 37065938Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health.Translational medicine communications2023name in abstract: Oncorine
PMID 37208018Intratumoral injection of oncolytic virus (H101) in combination with concurrent chemoradiotherapy for locally advanced cervical cancer.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society2023name in title: H101
PMID 38046281Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy.Drug design, development and therapy2023name in title: Recombinant Human Adenovirus Type 5 H101
PMID 38152740Retracted: Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis.Applied bionics and biomechanics2023name in title: H101
PMID 34958003Ubiquitination and degradation of MGMT by TRIM72 increases the sensitivity of uveal melanoma cells to Dacarbazine treatment.Cancer biomarkers : section A of Disease markers2022name in abstract: Oncolytic Adenovirus H101
PMID 35273918Corrigendum: A Recombinant Human Adenovirus Type 5 (H101) Combined With Chemotherapy for Advanced Gastric Carcinoma: A Retrospective Cohort Study.Frontiers in oncology2022name in title: Recombinant Human Adenovirus Type 5 H101
PMID 35574359Efficacy and Safety of Recombinant Human Adenovirus Type 5 (H101) in Persistent, Recurrent, or Metastatic Gynecologic Malignancies: A Retrospective Study.Frontiers in oncology2022name in title: Recombinant Human Adenovirus Type 5 H101
PMID 35756634Role of Adenoviruses in Cancer Therapy.Frontiers in oncology2022name in abstract: Oncorine
PMID 35762456Oncolytic adenovirus H101 ameliorate the efficacy of anti-PD-1 monotherapy in colorectal cancer.Cancer medicine2022name in title: Oncolytic Adenovirus H101
PMID 36091626Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis.Applied bionics and biomechanics2022name in title: H101
PMID 33687882Oncolytic Adenovirus H101 Synergizes with Radiation in Cervical Cancer Cells.Current cancer drug targets2021name in title: Oncolytic Adenovirus H101
PMID 34332576A review on the advances and challenges of immunotherapy for head and neck cancer.Cancer cell international2021name in abstract: Oncorine
PMID 34956877A Recombinant Human Adenovirus Type 5 (H101) Combined With Chemotherapy for Advanced Gastric Carcinoma: A Retrospective Cohort Study.Frontiers in oncology2021name in title: Recombinant Human Adenovirus Type 5 H101
PMID 35116288The efficacy and safety of oncolytic viruses in the treatment of intermediate to advanced solid tumors: a systematic review and meta-analysis.Translational cancer research2021name in abstract: Oncolytic Adenovirus H101
PMID 32163385[Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer].Molekuliarnaia biologiia2020name in abstract: Oncorine
PMID 33376352Overexpression of LncRNA SNHG1 Were Suitable for Oncolytic Adenoviruse H101 Therapy in Oral Squamous-Cell Carcinoma.OncoTargets and therapy2020name in title: H101
PMID 30320917The oncolytic virus H101 combined with GNAQ siRNA-mediated knockdown reduces uveal melanoma cell viability.Journal of cellular biochemistry2019name in title: H101
PMID 29189159Oncorine, the World First Oncolytic Virus Medicine and its Update in China.Current cancer drug targets2018name in title: Oncorine
PMID 29284308Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.Human gene therapy2018name in abstract: Oncorine
PMID 29334764Development of Gene Therapeutics for Head and Neck Cancer in China: From Bench to Bedside.Human gene therapy2018name in abstract: Oncorine
PMID 28278076Adenovirus-based strategies enhance antitumor capability through p53-mediated downregulation of MGMT in uveal melanoma.Cancer biology & therapy2017name in abstract: Oncolytic Adenovirus H101
PMID 28355305Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.PloS one2017name in title: H101
PMID 28599488Histone deacetylase inhibitor trichostatin A enhances the antitumor effect of the oncolytic adenovirus H101 on esophageal squamous cell carcinoma in vitro and in vivo.Oncology letters2017name in title: Oncolytic Adenovirus H101
PMID 28664952Quantifying ultrafast charge carrier injection from methylammonium lead iodide into the hole-transport material H101 and mesoporous TiO2 using Vis-NIR transient absorption.Physical chemistry chemical physics : PCCP2017name in title: H101
PMID 28728568Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.Chinese journal of cancer2017name in title: Recombinant Human Adenovirus Type 5 H101
PMID 28782065Photoinduced dynamics of the hole-transport material H101 in organic solvents and on mesoporous Al2O3 and TiO2 thin films.Physical chemistry chemical physics : PCCP2017name in title: H101
PMID 26081001The antitumor effects of oncolytic adenovirus H101 against lung cancer.International journal of oncology2015name in title: Oncolytic Adenovirus H101
PMID 26259388Strategies used in the clinical trials of gene therapy for cancer.Journal of experimental therapeutics & oncology2015name in abstract: Oncorine
PMID 26470869Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC).BMC cancer2015name in title: H101
PMID 25468274DA virus mutant H101 has altered CNS pathogenesis and causes immunosuppression.Journal of neuroimmunology2014name in title: H101
PMID 21740357Clinical development of oncolytic viruses in China.Current pharmaceutical biotechnology2012name in abstract: Oncorine
PMID 22843987Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines.The British journal of ophthalmology2012name in title: Oncolytic Adenovirus H101
PMID 22937170Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors.PloS one2012name in abstract: Oncolytic Adenovirus H101
PMID 22992863Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer.International journal of molecular medicine2012name in title: Oncolytic Adenovirus H101
PMID 23021247Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans.Advances in cancer research2012name in abstract: Oncorine
PMID 24236929Oncolytic virus therapies.Pharmaceutical patent analyst2012name in abstract: Oncorine
PMID 22335946[Effect of CEA gene regulation on the anti-tumor activity of oncolytic adenovirus H101 to esophageal carcinoma].Zhonghua zhong liu za zhi [Chinese journal of oncology]2011name in title: Oncolytic Adenovirus H101
PMID 20007825Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.Investigative ophthalmology & visual science2010name in title: Oncolytic Adenovirus H101
Unconfirmed matches (45)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 41268599[Expression of Concern] Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin‑like growth factor 2 imprinting.International journal of oncology2026name in abstract: H101
PMID 41827827Oncolytic Viruses in Cancer Immunotherapy: From Molecular Engineering to Clinical Translation.Cells2026name in abstract: H101
PMID 42025901Efficacy of oncolytic viruses (OVs) in malignant tumor therapy: a review on its therapeutic aspects.Clinica chimica acta; international journal of clinical chemistry2026name in abstract: H101
PMID 42909267Liver-resident cellular determinants of oncolytic virotherapy in hepatocellular carcinoma: viral susceptibility and spatial immune remodeling.Frontiers in cell and developmental biology2026name in abstract: H101
PMID 40948961Live culture-based qPCR screening of Taq DNA polymerase variants for resistance to PCR inhibitors.Frontiers in bioengineering and biotechnology2025name in abstract: H101
PMID 41040530Recombinant human adenovirus type 5 administration for the treatment of malignant ascites or pleural effusion in cancer patients: a meta-analysis.Frontiers in oncology2025name in abstract: H101
PMID 38180875The Arabidopsis SR45 splicing factor bridges the splicing machinery and the exon-exon junction complex.Journal of experimental botany2024name in abstract: H101
PMID 39030309Recombinant human adenovirus type 5 promotes anti-tumor immunity via inducing pyroptosis in tumor endothelial cells.Acta pharmacologica Sinica2024name in abstract: H101
PMID 39227421Balancing volumetric and gravimetric capacity for hydrogen in supramolecular crystals.Nature chemistry2024name in abstract: H101
PMID 39293238Breaking Barriers: Animal viruses as oncolytic and immunotherapeutic agents for human cancers.Virology2024name in abstract: H101
PMID 37214817Comparing FRET pairs that report on intersubunit rotation in bacterial ribosomes.bioRxiv : the preprint server for biology2023name in abstract: H101
PMID 37348753Comparing FRET Pairs that Report on Intersubunit Rotation in Bacterial Ribosomes.Journal of molecular biology2023name in abstract: H101
PMID 37620054Isolation and genome sequencing of a novel lytic Pseudoalteromonas phage SL20.Marine genomics2023name in abstract: H101
PMID 37801472Partial spontaneous intersubunit rotations in pretranslocation ribosomes.Proceedings of the National Academy of Sciences of the United States of America2023name in abstract: H101
PMID 34225616H101G Mutation in Rat Lens αB-Crystallin Alters Chaperone Activity and Divalent Metal Ion Binding.Current pharmaceutical biotechnology2022name in abstract: H101
PMID 35027480Novel Group C Oncolytic Adenoviruses Carrying a miRNA Inhibitor Demonstrate Enhanced Oncolytic Activity In Vitro and In Vivo.Molecular cancer therapeutics2022name in abstract: H101
PMID 35131956Discovery of Chitin Deacetylase Inhibitors through Structure-Based Virtual Screening and Biological Assays.Journal of microbiology and biotechnology2022name in abstract: H101
PMID 35715049Identification and antioxidant capacity of 4-hydroxyphenylpyruvate dioxygenase (HPPD), a new favored herbicide target, in Apis cerana cerana.Pesticide biochemistry and physiology2022name in abstract: H101
PMID 35836877Advances in the clinical development of oncolytic viruses.American journal of translational research2022name in abstract: H101
PMID 35425109Exploration of conjugated π-bridge units in N,N-bis(4-methoxyphenyl)naphthalen-2-amine derivative-based hole transporting materials for perovskite solar cell applications: a DFT and experimental investigation.RSC advances2021name in abstract: H101
PMID 33182528A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma.Cells2020name in abstract: H101
PMID 33281788Altering Intracellular Localization of the RNA Interference Factors by Influenza A Virus Non-structural Protein 1.Frontiers in microbiology2020name in abstract: H101
PMID 31144549Achieving systemic delivery of oncolytic viruses.Expert opinion on drug delivery2019name in abstract: H101
PMID 31933185Current Prospects of Molecular Therapeutics in Head and Neck Squamous Cell Carcinoma.Pharmaceutical medicine2019name in abstract: H101
PMID 29435900Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract2018name in abstract: H101
PMID 28741149The role of peripheral interleukin-6 in the development of acute seizures following virus encephalitis.Journal of neurovirology2017name in abstract: H101
PMID 29302257ELISA for Quantitative Determination of Hepatitis B Virus Surface Antigen.Immune network2017name in abstract: H101
PMID 27391605Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector.PloS one2016name in abstract: H101
PMID 27717041Effects of Gabra2 Point Mutations on Alcohol Intake: Increased Binge-Like and Blunted Chronic Drinking by Mice.Alcoholism, clinical and experimental research2016name in abstract: H101
PMID 25652289Identification and analysis of icCu/Zn-SOD, Mn-SOD and ecCu/Zn-SOD in superoxide dismutase multigene family of Pseudosciaena crocea.Fish & shellfish immunology2015name in abstract: H101
PMID 26561828Oncolytic Replication of E1b-Deleted Adenoviruses.Viruses2015name in abstract: H101
PMID 24634079A simple 3,4-ethylenedioxythiophene based hole-transporting material for perovskite solar cells.Angewandte Chemie (International ed. in English)2014name in abstract: H101
PMID 25364261Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives.OncoTargets and therapy2014name in abstract: H101
PMID 23308109A unified model of the GABA(A) receptor comprising agonist and benzodiazepine binding sites.PloS one2013name in abstract: H101
PMID 24269822An oncolytic adenovirus enhances antiangiogenic and antitumoral effects of a replication-deficient adenovirus encoding endostatin by rescuing its selective replication in nasopharyngeal carcinoma cells.Biochemical and biophysical research communications2013name in abstract: H101
PMID 22280899Microbacterium marinum sp. nov., isolated from deep-sea water.Systematic and applied microbiology2012name in abstract: H101
PMID 22336909Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block.Cancer biology & therapy2012name in abstract: H101
PMID 22880939Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets.Expert opinion on therapeutic targets2012name in abstract: H101
PMID 23071601A novel anticancer therapy that simultaneously targets aberrant p53 and Notch activities in tumors.PloS one2012name in abstract: H101
PMID 23240001Crystal structure of two anti-porphyrin antibodies with peroxidase activity.PloS one2012name in abstract: H101
PMID 21630357A missense mutation in CLIC2 associated with intellectual disability is predicted by in silico modeling to affect protein stability and dynamics.Proteins2011name in abstract: H101
PMID 21680509Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection.Journal of virology2011name in abstract: H101
PMID 22295575[Binding of human ribosomal protein S13 to the central domain of 18S rRNA].Molekuliarnaia biologiia2011name in abstract: H101
PMID 20487541Increased plasma membrane cholesterol in cystic fibrosis cells correlates with CFTR genotype and depends on de novo cholesterol synthesis.Respiratory research2010name in abstract: H101
PMID 19018252Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors.Molecular therapy : the journal of the American Society of Gene Therapy2009name in abstract: H101

NIH grants

No confirmed grants yet.

Unconfirmed matches (1)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

ProjectTitleOrganisationPIYearsLinked by
R56CA102053Spread of Replicating Adenovirus in Solid TumorsNEW YORK UNIVERSITY SCHOOL OF MEDICINEHAY, JOHN G.2009–2009name in abstract: H101

Notes

Approved in China 2005 as Oncorine; no INN, so the code H101 is the preferred name. Construct description not re-verified from a primary source.

How to cite

H101 (AXP000003.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000003.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.